Showing results (411-420 of 579) with videos related to
Sort By:
Pageof 58
The Quarterly Journal of Medicine|October 1, 1975
Studies of vitamin D deficiency in manM A Preece, TomlinsonS, C A Ribot, et al.Chemical Communications (Cambridge, England)|February 6, 2014
The first intramolecular silene Diels-Alder reactionsMichal Czyzewski, Jonathan D Sellars, Tamaz Guliashvili, et al.Allergy|January 26, 2011
Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severityS Kezic, G M O'Regan, N Yau, et al.Plos One|June 4, 2009
Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohortSantiago Rodriguez, Amanda J Hall, Raquel Granell, et al.The British Journal of Dermatology|August 19, 2016
Mutations in desmoglein 1 cause diverse inherited palmoplantar keratoderma phenotypes: implications for genetic screeningM-L Lovgren, M A McAleer, A D Irvine, et al.British Medical Journal|January 8, 1977
Comprehensive clinical drug information service: first year's experienceD M Davies, C H Ashton, J G Rao, et al.The British Journal of Dermatology|April 26, 2018
Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitisM A McAleer, I Jakasa, N Raj, et al.Nature|August 10, 2000
Fringe is a glycosyltransferase that modifies NotchD J Moloney, V M Panin, S H Johnston, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2025
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by AgeMichael J Cork, Mette Deleuran, Bob Geng, et al.Journal of the American Academy of Dermatology|December 6, 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trialLisa A Beck, Thomas Bieber, Stephan Weidinger, et al.Pageof 58